收藏切换
The system design for early resolution mechanism for drug patent disputes with Chinese characteristics—From the perspective of comparison between foreign experience and domestic current situation
收藏切换
Cong WEI1, Tian TIAN1, Guo-shun DU1, Xin YIN2
Chinese Journal of New Drugs | 2021, 30(15) : 1345 - 1354
Less
收藏切换
Chinese Journal of New Drugs | 2021, 30(15): 1345-1354
The system design for early resolution mechanism for drug patent disputes with Chinese characteristics—From the perspective of comparison between foreign experience and domestic current situation
Full
Cong WEI1, Tian TIAN1, Guo-shun DU1, Xin YIN2
Affiliations
  • 1Reexamination and Invalidation Department of the Patent Office, China National Intellectual Property Administration, Beijing 100088, China
  • 2Capital Normal University, Beijing 100037, China
Published: 2021-08-15
Outline
收藏切换

The drug patent link system has been implemented in our country with the implementation of the new Patent Law of China on June 1st, 2021 and the implementation of “Early Resolution Mechanism for Drug Patent Disputes” on July 4th. To ensure the successful implementation of the patent link system, this paper analyzes the key elements of early resolution mechanism for drug patent disputes with Chinese characteristics, based on a comparative study of the overall framework of the drug patent link system in the United States, South Korea and Canada, combined with the development status and legislation of China's pharmaceutical industry at this stage. On the basis of the above, according to the reality of pharmaceutical industry, the characteristics of judicial and administrative systems in our country, this paper explores the early resolution mechanism for drug patent disputes suitable for China's national conditions under the framework principles established by the new Patent Law.

drug patent link system  /  early resolution mechanism for drug patent disputes  /  dual track system  /  orange book  /  approval waiting period  /  market exclusivity period for the first generic drug
魏聪, 田甜, 杜国顺, 尹昕. 中国特色药品专利纠纷早期解决机制的制度设计——以国外经验与国内现状的对比为视角. 中国新药杂志, 2021 , 30 (15) : 1345 -1354 .
Cong WEI, Tian TIAN, Guo-shun DU, Xin YIN. The system design for early resolution mechanism for drug patent disputes with Chinese characteristics—From the perspective of comparison between foreign experience and domestic current situation[J]. Chinese Journal of New Drugs, 2021 , 30 (15) : 1345 -1354 .
Year 2021 volume 30 Issue 15
49
10
Cite this Article
BibTeX
Article Info
  • Online Date:2026-10-28
  • Published:2021-08-15
Article Data
Affiliations
History
  • Accepted:2021-05-13
Funding
Affiliations
    1Reexamination and Invalidation Department of the Patent Office, China National Intellectual Property Administration, Beijing 100088, China
    2Capital Normal University, Beijing 100037, China
References
Share
https://castjournals.cast.org.cn/joweb/zgxyzz/EN/
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT